Pharma accused of restricting access to hep C drug in poor countries

Sarah Bosley in The Guardian

 Pharma accused of restricting access to hep C drug in poor countriesThe Guardian "New drugs for hepatitis C are a major breakthrough but hugely expensive in rich countries. Pharma giant Gilead will allow cheap copies to be made for poor countries - but only for patients with proof of identification and citizenship and the drug supplies will be closely tracked." (Photo: Médecins du Monde à Barmane/Frédéric de La Mure, MAEDI)

www.theguardian.com

Newsletter abonnieren